Join the Banzel group to help and get support from people like you.
Banzel News
Eisai Receives Approval for Antiepileptic Drug Banzel (rufinamide) As Adjunctive Treatment For Pediatric Patients
Tokyo, Japan – February 16, 2015 – Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. has received approval of an additional pediatric indication for Eisai’s antiepileptic drug (...
FDA Approves Banzel (rufinamide) Oral Suspension, 40 mg/mL
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Mar 4, 2011 - Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Banzel (rufinamide) Oral Suspension, 40 mg/mL, for the...
Ask a question
To post your own question to this support group, sign in or create an account.